Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023100 · ClinicalTrials.gov registry record · Phase 1
A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01023100: Completed Phase 1 study, sponsored by Pfizer.
NCT01023100 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023100, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.
Interventions
- DRUG CP 690,550 oral solutions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
What the finished NCT01023100 record still lists
NCT01023100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which CP 690,550 oral solutions is the first listed.
NCT01023100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01023100 about?
NCT01023100 is a clinical study titled "A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers". This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.
What is the current status of trial NCT01023100?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2010-03. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01023100?
The interventions under investigation include: CP 690,550 oral solutions (DRUG).
Who is sponsoring clinical trial NCT01023100?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01023100's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia